Satisfaction with medication in older people with type 2 diabetes

• Research type

  Research Study

• Full title

  Understanding the nature, meaning and importance of satisfaction with glucose-lowering medication in older people with type 2 diabetes

• IRAS ID

  127357

• Contact name

  Chaya Langerman

• Contact email

  haya.langerman@merck.com

• Sponsor organisation

  University of Bedfordshire

• Research summary

  Type 2 diabetes is a global health problem. Diabetes is up to five times more prevalent in patients aged 65 years or older, compared with patients below the age of 65. It can lead to serious acute and chronic complications if poorly managed. Adherence to treatment is a key factor in achieving therapeutic success, and non-adherence results in serious clinical and economic consequences. Patient satisfaction with their medication predicts continuance of pharmaceutical treatment, correct medication use and compliance with medication regimens. High satisfaction has been shown to be associated with better glycaemic control and a lower incidence of morbidity.Older people have been shown to have lower levels of adherence to treatment. What is not clear is if this poor adherence to treatment is related to their satisfaction with therapy.
  This study will address the following: what is the nature, meaning and importance of satisfaction with glucose-lowering medication in older people with type 2 diabetes? We seek answers to these questions from patients (and carers), healthcare professionals and pharmaceutical physicians. The study consists of four stages:
  1. Literature review in the area of medication satisfaction.
  2. Questionnaires for healthcare professionals- 50 will be handed or posted (10 consultants, 10 general practitioners, 20 nurses, 10 pharmacists)
  3. Three focus groups: I- patients and carers (patients over 65 years), II- healthcare professionals (general practitioners, diabetologists, diabetes specialist nurses, pharmacists) III- pharmaceutical physicians
  4. Semi structured interviews with 6 patients +/- carers

  Patients will be sought from primary care practices in Bedfordshire. Seven GP practices in Luton will be approached to ask for their cooperation with the study.
  Views and opinions will be sought from consultant diabetologists at the Luton and Dunstable university hospital.
  This stage is likely to last for 12 months.

• REC name

  Yorkshire & The Humber - Leeds West Research Ethics Committee

• REC reference

  14/YH/1063

• Date of REC Opinion

  1 Jul 2014

• REC opinion

  Unfavourable Opinion